enGenes presenting -excite Continuous Manufacturing technology to EFIB 2021 Vienna

Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) will present its innovative decoupled Continuous Manufacturing (CM) protein expression technology to the upcoming European Forum for Industrial Biotechnology & the Bioeconomy (EFIB 2021) meeting in Vienna.

This is a return to EFIB for enGenes, who made their first Forum appearance in 2019.

enGenes-eXcite Continuous Manufacturing breakthrough

enGenes will also participate across the range of face-to-face and virtual partnering meetings hosted at the EFIB Forum.

Dr. Mairhofer, enGenes CEO and co-founder, will also be one of the panel of speakers during Day Two’s Parallel Session B on ‘Bioprocesses: Next-generation impact on industrial manufacturing’ (October 7: 1100-1215 hrs. CET).

He will explain how enGenes-eXcite CM technology, on which the company has recently filed a patent application, is based on its equally innovative -eXpress expression platform.

Form more information follow https://www.pharmaceutical-networking.com/engenes-presenting-x-cite-continuous-manufacturing-technology-to-efib-2021-vienna/